Efficacy and Safety of Prolonged-Release Lanreotide in Patients With Gastrointestinal Neuroendocrine Tumors and Hormone-Related Symptoms

Octreotide

1996 • 956 citations

Treatment of the Malignant Carcinoid Syndrome

1986 • 852 citations

Karnofsky memorial lecture. An odyssey in the land of small tumors.

1987 • 465 citations

The Management of Patients with Advanced Carcinoid Tumors and Islet Cell Carcinomas

1994 • 293 citations

Effects of Leukocyte Interferon on Clinical Symptoms and Hormone Levels in Patients with Mid-Gut Carcinoid Tumors and Carcinoid Syndrome

1983 • 279 citations

Treatment of the carcinoid syndrome with the longacting somatostatin analogue lanreotide: a prospective study in 39 patients.

1996 • 205 citations

Therapy of metastatic carcinoid tumor and the malignant carcinoid syndrome with recombinant leukocyte A interferon.

1989 • 168 citations

Quality of life of Danish women: population-based norms of the EORTC QLQ-C30.

1997 • 141 citations

Pharmacokinetics and efficacy of a long-acting formulation of the new somatostatin analog BIM 23014 in patients with acromegaly.

1993 • 118 citations

Neuroendocrine gastrointestinal tumours

1996 • 107 citations

Incidence and morbidity of cholelithiasis in patients receiving chronic octreotide for metastatic carcinoid and malignant islet cell tumors

1997 • 102 citations

Incidence and morbidity of cholelithiasis in patients receiving chronic octreotide for metastatic carcinoid and malignant islet cell tumors

1997 • 100 citations

Gallstones during octreotide therapy

1992 • 99 citations

Treatment with a Somatostatin Analog Decreases Pancreatic B-Cell and Whole Body Sensitivity to Glucose*

1990 • 95 citations

Octreotide-associated biliary tract dysfunction and gallstone formation: pathophysiology and management.

1995 • 83 citations

Lanreotide in the treatment of patients with thyroid eye disease

1997 • 69 citations

Recombinant interferon alpha-2b in patients with metastatic apudomas: effect on tumours and tumour markers

1992 • 59 citations

Pharmacokinetics and efficacy of a long-acting formulation of the new somatostatin analog BIM 23014 in patients with acromegaly

1993 • 44 citations

Treatment of neuroendocrine tumors

1994 • 35 citations

Recent Developments in Diagnosis and Treatment of Metastatic Carcinoid Tumours

1993 • 31 citations

Liver metastases of digestive endocrine tumours: natural history and response to medical treatment.

1996 • 23 citations

Effects of the new somatostatin analogue (BIM 23014) on blood glucose homeostasis in normal men

1992 • 21 citations

Deleted Work

1955 • 0 citations